Professor of clinical science with leadership pedigree in academia, NHS and GlaxoSmithKline (GSK) and respected for this relatively unusual combination of experiences. Now continuing in academia with Consultancy roles, Scientific Review Boards including Horizon 2020 programmes, honorary chair at University of Birmingham & Academy of Medical Sciences, plus serving as a Kidney Research UK Trustee, the leading kidney disease research charity (www.kidneyresearchuk.org). As a KRUK Trustee, chair the Development Advisory Board looking to explore alternative ways of funding to expedite new technologies and treatments to benefit kidney patients. Also, actively considering non-exec director roles in biotech and pharma.